| Data |
Ora |
Fonte |
Titolo |
|---|
| 14/5/2024 | 22:05 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 02/5/2024 | 13:00 | PRNUS | Acurx Pharmaceuticals Announces Presentation of Ibezapolstat.. |
| 25/4/2024 | 16:12 | PRNUS | Acurx Pharmaceuticals Announces Presentation of.. |
| 23/4/2024 | 16:57 | PRNUS | Acurx Pharmaceuticals, Inc. to Discuss First Quarter 2024.. |
| 19/3/2024 | 12:33 | IHMARKETNEWS | Unilever Initiates Ice Cream Division Spin-Off and Announces.. |
| 18/3/2024 | 12:12 | IHMARKETNEWS | Anticipation Builds on Wall Street for Federal Reserve’s.. |
| 18/3/2024 | 12:01 | PRNUS | Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full.. |
| 04/3/2024 | 13:01 | PRNUS | Acurx Pharmaceuticals, Inc. to Discuss Fourth Quarter and.. |
| 27/2/2024 | 13:01 | PRNUS | Acurx Announces FDA Has Granted an End of Phase 2 Meeting.. |
| 23/2/2024 | 15:30 | GLOBE | New to The Street Announces Line-up of its Corporate.. |
| 16/2/2024 | 15:30 | GLOBE | New to The Street Airs Episode 556 Featuring Five Corporate.. |
| 02/2/2024 | 15:30 | GLOBE | New to The Street Announces its 553rd Episode TV Line Up,.. |
| 01/2/2024 | 15:33 | GLOBE | New to The Street TV Announces Episode #552 with its Five.. |
| 29/1/2024 | 13:00 | PRNUS | Acurx Announces Positive Extended Clinical Cure Data for.. |
| 26/1/2024 | 16:55 | GLOBE | New to The Street Announces Episode 551, Five Corporate.. |
| 23/1/2024 | 13:01 | PRNUS | Acurx Pharmaceuticals to Present at the Microcap Conference,.. |
| 22/1/2024 | 12:15 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 19/1/2024 | 15:30 | GLOBE | New to The Street Airs on the FOX Business Network, Episode.. |
| 17/1/2024 | 13:01 | PRNUS | Acurx Announces Positive Comparative Microbiology and.. |
| 05/1/2024 | 15:30 | GLOBE | New to The Street Announces its Four Corporate Interviews,.. |
| 03/1/2024 | 14:00 | PRNUS | Acurx to present at the 42nd Annual J.P. Morgan Healthcare.. |
| 11/12/2023 | 13:01 | PRNUS | Acurx Announces Positive Phase 2b Results Showing 100% of.. |
| 08/12/2023 | 15:46 | GLOBE | New to The Street TV Features Five Corporate Guest.. |
| 07/12/2023 | 15:20 | GLOBE | New to The Street TV Announces Its Episode 536 Lineup, Five.. |
| 01/12/2023 | 15:30 | GLOBE | New to The Street Announces Five Corporate Interviews,.. |
| 24/11/2023 | 15:30 | GLOBE | New to The Street Announces its Five Business Guest.. |
| 17/11/2023 | 15:30 | GLOBE | New to The Street Announces Episode 530 with Six Corporate.. |
| 15/11/2023 | 23:02 | EDGAR2 | Form 8-K - Current report |
| 15/11/2023 | 22:49 | EDGAR2 | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 14/11/2023 | 13:01 | PRNUS | Acurx Pharmaceuticals, Inc. Reports Third Quarter 2023.. |
| 02/11/2023 | 12:01 | PRNUS | Acurx Announces Positive Top-Line Ibezapolstat Phase 2.. |
| 25/10/2023 | 13:01 | PRNUS | Acurx Pharmaceuticals to Discuss Third Quarter 2023.. |
| 20/10/2023 | 16:43 | GLOBE | New to The Street Announces Six Business Interviews on its.. |
| 19/10/2023 | 13:01 | PRNUS | Acurx Announces Ibezapolstat Scientific Posters and.. |
| 02/10/2023 | 13:01 | PRNUS | Acurx Pharmaceuticals Announces Successful Completion and.. |
| 12/9/2023 | 13:01 | PRNUS | Acurx Announces Presentation and Update of Its pol IIIC R&D.. |
| 22/8/2023 | 13:01 | PRNUS | Acurx Pharmaceuticals to Present at the H.C. Wainwright 25th.. |
| 14/8/2023 | 13:01 | PRNUS | Acurx Pharmaceuticals, Inc. Reports Second Quarter 2023.. |
| 24/7/2023 | 13:01 | PRNUS | Acurx Pharmaceuticals to Discuss Second Quarter 2023.. |
| 13/7/2023 | 22:32 | EDGAR2 | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 11/7/2023 | 06:15 | EDGAR2 | Form EFFECT - Notice of Effectiveness |
| 07/7/2023 | 15:30 | GLOBE | New to The Street Airs its Televised Corporate Interviews on.. |
| 30/6/2023 | 15:35 | GLOBE | New to The Street TV / Newsmax TV Announces its Five.. |
| 20/6/2023 | 13:01 | PRNUS | Acurx Pharmaceuticals to Present at the Emerging Growth.. |
| 15/6/2023 | 13:01 | PRNUS | Acurx Pharmaceuticals to Participate in the Maxim Group LLC.. |
| 16/5/2023 | 14:45 | PRNUS | Acurx Pharmaceuticals, Inc. Announces Pricing of $4.0.. |
